[
  {
    "Gene": "SNCA",
    "Protein Change": {
      "ref": "E",
      "alt": "K",
      "position": 46
    },
    "ACMG Assessment": {
      "Step 1": {
        "Question": "Is the disease mechanism clearly defined?",
        "Answer": "Yes",
        "Judgment": "Disease mechanism is about aberrant polymerization causing pathological inclusions leading to disease."
      },
      "Step 2": {
        "Question": "Is the assay class applicable?",
        "Answer": "Yes",
        "Judgment": "The assay studies propensity for amyloid fibrillization, directly related to the disease mechanism."
      },
      "Step 3": {
        "Sub-step 3a": {
          "Question": "Were basic controls and replicates included?",
          "Answer": "Controls (wild-type vs mutant) are used. Replicates not explicitly mentioned.",
          "Judgment": "No on replicates, proceed to Sub-step 3b."
        },
        "Sub-step 3b": {
          "Question": "Is the assay broadly accepted or validated?",
          "Answer": "Yes",
          "Judgment": "The assay is a standard method for studying protein aggregation."
        }
      },
      "Step 4": {
        "Sub-step 4a": {
          "Question": "Are statistical analyses sufficient?",
          "Answer": "No",
          "Judgment": "Proceed to Sub-step 4b."
        },
        "Sub-step 4b": {
          "Question": "How many controls were used?",
          "Answer": "Total of 2 (wild-type and A53T). Less than 10.",
          "Judgment": "Functional evidence strength is PS3_supporting."
        }
      },
      "Evidence Strength": "PS3_supporting"
    },
    "variant_string_id": "SNCA_E46K"
  },
  {
    "Gene": "SNCA",
    "Protein Change": {
      "ref": "A",
      "alt": "T",
      "position": 53
    },
    "ACMG Assessment": {
      "Step 1": {
        "Question": "Is the disease mechanism clearly defined?",
        "Answer": "Yes",
        "Judgment": "Disease mechanism is about aberrant polymerization causing pathological inclusions leading to disease."
      },
      "Step 2": {
        "Question": "Is the assay class applicable?",
        "Answer": "Yes",
        "Judgment": "The assay studies propensity for amyloid fibrillization, directly related to the disease mechanism."
      },
      "Step 3": {
        "Sub-step 3a": {
          "Question": "Were basic controls and replicates included?",
          "Answer": "Controls (wild-type vs mutant) are used. Replicates not explicitly mentioned.",
          "Judgment": "No on replicates, proceed to Sub-step 3b."
        },
        "Sub-step 3b": {
          "Question": "Is the assay broadly accepted or validated?",
          "Answer": "Yes",
          "Judgment": "The assay is a standard method for studying protein aggregation."
        }
      },
      "Step 4": {
        "Sub-step 4a": {
          "Question": "Are statistical analyses sufficient?",
          "Answer": "No",
          "Judgment": "Proceed to Sub-step 4b."
        },
        "Sub-step 4b": {
          "Question": "How many controls were used?",
          "Answer": "Total of 2 (wild-type and E46K). Less than 10.",
          "Judgment": "Functional evidence strength is PS3_supporting."
        }
      },
      "Evidence Strength": "PS3_supporting"
    },
    "variant_string_id": "SNCA_A53T"
  }
]